Search
Sumario de resultados
TIpos de contenido
Fecha
-
Press release86 AseBio members working on new solutions to tackle the challenges of the Green Transitio...
The report prepared by AseBio as an initiative of its Sustainability Committee identifies 587 solutions focused on identifying and adopting new ways of production and consumption that respect the
-
NewNatac, part of the European OliWa project to reuse olive tree biomass
The initiative focuses on the transformation of this biomass into animal feed, functional additives, environmentally friendly packaging, and biogas
-
CompanyMAIEUTICS RESEARCH SOLUTIONS
-
NewNext-generation CAR-T therapies for pediatric sarcomas: Biotechnological advances show pro...
The CIBER Cancer Area (CIBERONC) is developing advanced cellular therapies targeting pediatric sarcomas, with a special focus on Ewing sarcoma.
-
Press release
Next-generation CAR-T therapies for pediatric sarcomas: Biotechnological advances show pro...
The World Health Organization recognizes over 150 different types of sarcomas, a rare disease that poses significant diagnostic and therapeutic challenges. The CIBER Cancer Area (CIBERONC) is
-
New#NewAseBioMember | "AseBio is a key player in Spain's biotech ecosystem"
Meet our new member Inbistra. We spoke with Ignacio Sancho-Martinez CEO y co-fundadorr
-
CompanyPHARMABIOS INNOVA
-
New#NewAseBioAlly | "AseBio is a key reference point in Spain’s biotechnology ecosystem"
Meet IMCD, our new Ally. We spoke with Lander Elkoro, Market Manager Formulation & Biopharma Iberia.
-
NewName change from Leadartis and launch of new website
Trimerbody Pharma, a clinical-stage biopharmaceutical company developing proprietary therapeutic antibodies called Trimerbodies against cancer, announces that it has changed its name from Leadartis
-
NewADmit Therapeutics Relocates to New State-of-the-Art Facilities Within the Almirall’s Inn...
Biotech company ADmit Therapeutics has announced its move to new state-of-the-art facilities at “The Hive”, Almirall’s innovation hub in Sant Feliu de Llobregat. This strategic relocation strengthens
-
-
NewHow to Secure the EIC Transition Grant: 6 Key Lessons from a Spanish Success Story
The biotechnology company Viva In Vitro Diagnostics shares its experience during the CDTI and FECYT workshop, offering insight into accessing one of the EU’s most competitive programmes for disruptive
-
NewBCN HEALTH presents a systematic review evaluating the cost-effectiveness of tumor-infiltr...
BCN HEALTH presented the study “Economic evaluation of TIL-ACT with HD-IL-2: a systematic literature review of costs and cost-effectiveness” on June 19 in Madrid during the Annual Conference of the
-
CompanyINBISTRA
-
-
NewMayte Alonso joins PVpharm as Head of Operations to support international growth
La llegada de Mayte Alonso al equipo de PVpharm marca un paso más en la estrategia de expansión de la compañía en el ámbito de los servicios farmacéuticos globales.
-
NewNorayBio obtains the Certificate of Conformity with the National Security Framework
The ENS certificate obtained in the audit carried out by AENOR guarantees that NorayBio has the necessary security measures to protect its information systems, data and electronic services
-
NewAseBio Drives European Debate on Bioeconomy with the Organization of the "ShapingBio Summi...
In collaboration with the European ShapingBio consortium, of which AseBio is a member, the event brought together key players from across the European ecosystem who emphasized the urgent need for
-
-
NewAdvanced techniques to study intracellular nanoparticle trafficking
Dr María Navalón recently defended her doctoral thesis at IQS, in which she developed and perfected advanced microscopy methods to understand the behaviour of nanoparticles in the field of
-
New#NewAseBioMember|"AseBio is the meeting point of the biotech sector in Spain, a space to c...
Meet our new member SmartBio Analytics. Meet our new member Rafael Terán, General Manager.
